Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 155
- Registration Number
- NCT00545233
BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 585
- Registration Number
- NCT00545909
A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 716
- Registration Number
- NCT00545363
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2015-08-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 596
- Registration Number
- NCT00545480
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2019-01-16
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 86
- Registration Number
- NCT00545714
- Locations
- 🇪🇸
Hospital Clinico Universitario Lozano Blesa; Servicio de Hematologia, Zaragoza, Spain
🇪🇸Hospital Clinico Universitario de Salamanca;Servicio de Hematologia, Salamanca, Spain
🇪🇸Hospital Universitario Puerta del Mar; Servicio de Hematologia, Cádiz, Cadiz, Spain
ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 561
- Registration Number
- NCT00545090
A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 417
- Registration Number
- NCT00545688
- Locations
- 🇦🇺
Geelong Hospital; Andrew Love Cancer Centre, Geelong, Victoria, Australia
🇲🇽ARKE Estudios Clínicos S.A. de C.V., Mexico City, Mexico
🇮🇱Meir Medical Center; Oncology, Kfar-Saba, Israel
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 180
- Registration Number
- NCT00545402
MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2016-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 120
- Registration Number
- NCT00545571
A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-09-26
- Last Posted Date
- 2017-07-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 132
- Registration Number
- NCT00535782
- Locations
- 🇺🇸
Rheumatology Associates of North Alabama, Huntsville, Alabama, United States
🇺🇸Pinnacle Research Group; Llc, Central, Anniston, Alabama, United States
🇺🇸Arthritis & Rheumatism; Disease Specialities, Aventura, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath